Cargando…

Ultrasound-guided SoracteLite™ transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience

PURPOSE: To evaluate the efficacy and safety of ultrasound-guided transperineal laser ablation (TPLA) in patients with symptomatic BPH. MATERIALS AND METHODS: From January 2020 to January 2022, 63 prospectively enrolled patients underwent TPLA with a 1064-nm continuous-wave diode laser (EchoLaser, E...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laganà, Antonino, Di Lascio, Giovanni, Di Blasi, Aldo, Licari, Leslie Claire, Tufano, Antonio, Flammia, Rocco Simone, De Carolis, Andrea
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10160153/ https://www.ncbi.nlm.nih.gov/pubmed/36853444 http://dx.doi.org/10.1007/s00345-023-04322-1

Ejemplares similares

Transperineal Laser Ablation of the Prostate (TPLA) for Lower Urinary Tract Symptoms Due to Benign Prostatic Obstruction
por: Sessa, Francesco, et al.
Publicado: (2023)

Transperineal laser ablation (TPLA) with ultrasound/MRI fusion guidance in the treatment of localized radiotherapy-resistant prostate cancer
por: Manenti, Guglielmo, et al.
Publicado: (2023)

Safety and Feasibility of Soractelite Transperineal Focal Laser Ablation for Prostate Cancer and Short-term Quality of Life Analysis from a Multicenter Pilot Study
por: van Riel, Luigi A.M.J.G., et al.
Publicado: (2022)

Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
por: Sciacqua, L. V., et al.
Publicado: (2023)

Prostatic ischemia induces ventral prostatic hyperplasia in the SHR; possible mechanism of development of BPH
por: Saito, Motoaki, et al.
Publicado: (2014)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
por: Kang, JiHun
Publicado: (2021)

Outcomes and quality of life issues in the pharmacological management of benign prostatic hyperplasia (BPH)
por: Cambio, Angelo J, et al.
Publicado: (2007)

What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?
por: Foo, Keong Tatt
Publicado: (2019)

BPH and prostate cancer risk
por: Miah, Saiful, et al.
Publicado: (2014)

Long-term survival of stage A prostate carcinoma, atypical hyperplasia/adenosis and BPH.
por: Brawn, P. N., et al.
Publicado: (1994)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
por: Ko, Young Hwii, et al.
Publicado: (2010)

Early Experience with Laparoscopic Retropubic Simple Prostatectomy in Patients with Voluminous Benign Prostatic Hyperplasia (BPH)
por: Yun, Han Ki, et al.
Publicado: (2010)

Assessing the Influence of Benign Prostatic Hyperplasia (BPH) on Erectile Dysfunction (ED) among patients in Poland
por: Dutkiewicz, Sławomir, et al.
Publicado: (2012)

Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network
por: Hellwege, Jacklyn N., et al.
Publicado: (2019)

1-year cost-utility analysis of prostate artery embolization (PAE) versus transurethral resection of the prostate (TURP) in benign prostatic hyperplasia (BPH)
por: Patel, Nikisha, et al.
Publicado: (2021)

3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia
por: Manenti, Guglielmo, et al.
Publicado: (2021)

Hundred years of transperineal prostate biopsy
por: Schmeusser, Benjamin, et al.
Publicado: (2022)

Urinary Tract Symptoms (LUTS) Secondary to Benign Prostatic Hyperplasia (BPH) and LUTS/BPH with Erectile Dysfunction in Asian Men: A Systematic Review Focusing on Tadalafil
por: Park, Hyun Jun, et al.
Publicado: (2013)

Atypical granular cell tumor of the urinary bladder: A case report and literature review
por: Tufano, Antonio, et al.
Publicado: (2021)

Inflammatory Responses in a Benign Prostatic Hyperplasia Epithelial Cell Line (BPH-1) Infected with Trichomonas vaginalis
por: Kim, Sang-Su, et al.
Publicado: (2016)

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain
por: María Molero, José, et al.
Publicado: (2020)

Serenoa repens and Urtica dioica Fixed Combination: In-Vitro Validation of a Therapy for Benign Prostatic Hyperplasia (BPH)
por: Saponaro, Miriam, et al.
Publicado: (2020)

Therapeutic potential of pomegranate juice-derived nanovesicles in nude mouse benign prostatic hyperplasia (BPH) xenograft model
por: Sreekumar, Amritha, et al.
Publicado: (2023)

Transperineal prostate biopsy: a review of technique
por: Thomson, Alice, et al.
Publicado: (2020)

Inflammasomes are important mediators of prostatic inflammation associated with BPH
por: Kashyap, Mahendra, et al.
Publicado: (2015)

Development of Interpretable Predictive Models for BPH and Prostate Cancer
por: Bermejo, Pablo, et al.
Publicado: (2015)

The single nucleotide polymorphism rs700518 is an independent risk factor for metabolic syndrome and benign prostatic hyperplasia (MetS‐BPH)
por: Chen, Z.P., et al.
Publicado: (2018)

Administration of Caesalpinia bonduc Seed Extracts Ameliorates Testosterone-Induced Benign Prostatic Hyperplasia (BPH) in Male Wistar Rats
por: Sasidharan, Shan, et al.
Publicado: (2022)

Pooled outcomes of performing freehand transperineal prostate biopsy with the PrecisionPoint Transperineal Access System
por: Tzeng, Michael, et al.
Publicado: (2022)

The Design and Rationale of a Multicentre Randomised Controlled Trial Comparing Transperineal Percutaneous Laser Ablation With Transurethral Resection of the Prostate for Treating Benign Prostatic Hyperplasia
por: Zhang, Wei, et al.
Publicado: (2021)

The Role of TURP in the Detection of Prostate Cancer in BPH Patients with Previously Negative Prostate Biopsy
por: Kim, Dae Keun, et al.
Publicado: (2010)

Androgen Regulated Genes in Human Prostate Xenografts in Mice: Relation to BPH and Prostate Cancer
por: Love, Harold D., et al.
Publicado: (2009)

BiopSee(®) – transperineal stereotactic navigated prostate biopsy
por: Zogal, Pawel, et al.
Publicado: (2011)

Rebiopsy rate after transperineal or transrectal prostate biopsy
por: Marenco Jimenez, Jose L., et al.
Publicado: (2021)

Selenium in combination with a tomato lipid extract as a therapy for benign prostatic hyperplasia and its alterations in rats with induced BPH
por: Arias‐Chávez, David Julian, et al.
Publicado: (2023)

Analysis of prostate cancer localization toward improved diagnostic accuracy of transperineal prostate biopsy
por: Sakamoto, Yoshiro, et al.
Publicado: (2014)

Affordable novel device (VY) for transperineal prostate biopsy: A trial on prostate mannequin
por: Pramod, Sawkar Vijay, et al.
Publicado: (2021)

Variation of Serum PSA Levels in COVID-19 Infected Male Patients with Benign Prostatic Hyperplasia (BPH): A Prospective Cohort Studys
por: Cinislioglu, Ahmet Emre, et al.
Publicado: (2022)

Continued administration of antithrombotic agents during transperineal prostate biopsy
por: Asano, Toko, et al.
Publicado: (2015)

Transperineal biopsy of the prostate in a patient post abdominoperineal resection
por: Amin, Amer, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_g19lvdl9kora577bnr2hopj42t